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Abstract: Cerebral autoregulation (CA) mechanisms maintain blood flow approximately stable despite 
changes in arterial blood pressure. Mathematical models that characterise this system have been used 
extensively in the quantitative assessment of function/impairment of CA. Using spontaneous 
fluctuations in arterial blood pressure (ABP) as input and cerebral blood flow velocity (CBFV) as 
output, the autoregulatory mechanism can be modelled using linear and nonlinear approaches, from 
which indexes can be extracted to provide an overall assessment of CA. Previous studies have 
considered a single – or at most a couple of measures, making it difficult to compare the performance 
of different CA parameters. We compare the performance of established autoregulatory parameters and 
propose novel measures. The key objective is to identify which model and index can best distinguish 
between normal and impaired CA.  To this end twenty-six recordings of ABP and CBFV from 
normocapnia and hypercapnia (which temporarily impairs CA) in 13 healthy adults were analysed. In 
the absence of a ‘gold’ standard for the study of dynamic CA, lower inter- and intra-subject variability 
of the parameters in relation to the difference between normo- and hypercapnia were considered as 
criteria for identifying improved measures of CA. Significantly improved performance compared to 
some conventional approaches was achieved, with the simplest method emerging as probably the most 
promising for future studies.  
Keywords: blood flow, autoregulation, system identification, modelling. 
1.   Introduction 
The active control of the diameter of small cerebral blood vessels protects the brain against 
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injury due to insufficient or excessive blood flow following a temporary drop or surge in 
arterial blood pressure (ABP). This regulatory mechanism is usually referred to as Cerebral 
Autoregulation (CA). Autoregulation is of great clinical interest as it can be impaired or lost in 
a number of conditions, such as stroke [1], subarachnoid haemorrhage [2] or head trauma [3]. 
In much of the published literature, blood flow velocity is recorded by the safe and non-
invasive Doppler ultrasound method in response to transient changes in ABP. Sudden 
deflation of a thigh cuff, large sinusoidal variations in lower-body negative pressure, periodic 
breathing or squatting, and the Valsalva manoeuvre have all been used to provoke larger 
changes in ABP [4]. However the most desirable experimental protocol for assessing CA is to 
record data from subjects at rest without performing any specific manoeuvres; this is 
especially relevant for patients during surgery or in intensive care, those highly vulnerable 
(e.g. neonates), or otherwise unable or unwilling to cooperate. Many recent studies have thus 
focused on using only spontaneous fluctuations of ABP for the assessment of CA. Even 
though this approach increases challenges in terms of analysing the recorded signals, and intra 
and inter-subject variability is high, its effectiveness has been repeatedly demonstrated  [4-6]. 
Algorithms already described in the literature for estimating CA involve system identification 
(black-box modelling) to represent the relationship between ABP and cerebral blood flow 
velocity (CBFV). Most of the studies of CA focus on linear methods [5, 7-10] with the more 
recent inclusion of some nonlinear approaches [8, 10-13]. Although nonlinear techniques can 
provide improved model fits, their benefit in assessing CA is still unclear with few studies 
having systematically compared them to linear alternatives.  
In the investigation of CA from linear models, parameters extracted from the frequency-, the 
impulse- or step-response of the models have been used to grade CA. Examples of such 
autoregulatory parameters include gain, phase and coherence in selected frequency ranges [5, 
7, 8, 14], or alternatively features of the step-response - e.g. slopes or amplitudes at selected 
points [9, 14]. An alternative method is provided by the autoregulatory index ARI [15]: this 
varies from 0 (absent CA) to 9 (excellent CA), with each corresponding to a specific linear 
filter. The filter that best fits the data determines the ARI for the recording, and this can be 
applied to spontaneous as well as induced blood pressure variations [16, 17] . The correlation 
of the ABP and CBFV time series [18] known as the Mx index, has also been very extensively 
used (e.g. [19]). The majority of published studies have considered one or two measures of 
CA for the analysis of cerebral blood flow control from spontaneous variations [10, 14], and 
no single parameter has become accepted as a gold standard. To date, it is not clear which 
combination of model and parameter for the assessment of CA is the most appropriate for 
future research and clinical practice. 
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The exploratory work in the current paper aims to compare a range of alternatives and 
recommend most promising methods. We investigate the performance of both linear and 
nonlinear models, and compare different measures extracted from the models to assess CA. In 
the continuing absence of a gold standard measure of CA, the autoregulatory parameters are 
evaluated on a sample of signals recorded from healthy volunteers in whom temporary 
impairment of CA was induced by hypercapnia [20, 21]. Based on the results, we suggest 
some promising autoregulatory measures for application in future physiological and clinical 
studies. 
2. Methods 
2.1. Data Collection and pre-processing 
The study was performed on 13 healthy volunteer subjects (age 32 ± 8.8 years) and was 
approved by the local Research Ethics Committee. All recordings were made with subjects in 
the supine position with the head elevated. Middle cerebral artery velocity was measured 
using a Transcranial Doppler Ultrasound system (Scimed QVL-120) in conjunction with a 
2MHz transducer held in position by an elastic headband. Simultaneously arterial blood 
pressure (ABP) was non-invasively monitored using a finger cuff device (Ohmeda 2300 
Finapress Bp monitor). End-tidal CO2 (EtCO2) levels were monitored via an infra-red 
capnograph (Datex Normocap 200). Each recording began with a period of breathing ambient 
air for approximately 5 minutes, followed by approximately 2 minutes of elevated (EtCO2 ) 
due to the inhalation of 5% CO2 in air. 
The maximum velocity envelope and the ABP signals were digitised at 200 Hz. After the 
removal of spikes and other artefacts, the start of each heart cycle was automatically identified 
(with visual correction) from the ABP sigal, and average ABP and CBFVs were calculated for 
each heartbeat. This time series was then interpolated with a third-order polynomial, and 
sampled at a constant rate of 5 Hz. 
2.2. Modelling and Data Analysis 
For each subject a segment of data was selected from before (normocapnia – NC) and during 
5% CO2 breathing (hypercapnia – HC). The former were approx. 300 s long and the latter 120 
s. The initial transients at the onset of HC was removed until the signals were deemed stable, 
following visual inspection. The signals were decimated to a new sampling rate of 1Hz, 
following anti-alias filtering with a cut-off frequency at 0.5 Hz. These segments of the 
recordings were normalised by their respective mean values (as used in previous works e.g.[8, 
22, 23]), and the relative change (expressed in %) will be denoted by %ABP and %CBFV, 
respectively – see Figure 1. 
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For both linear and non-linear models, %ABP was the input and %CBFV the output. Linear 
models were estimated according to the usual least-mean-squares approach. A fifth order (6 
coefficient) FIR filter [6] was chosen in order to obtain a parsimonious model which includes 
the main early part of the autoregulatory response [6, 24]. The frequency response (‘transfer 
function’) was then obtained by applying the Fourier Transform to the impulse response. A 2nd 
order Volterra-Wiener model, as previously proposed [8, 12, 25], was also estimated using the 
Wiener-Laguerre (W-L) estimation procedure (for more details see for example [8]). The 
number of lags used for both the linear and nonlinear kernels was 12 samples (i.e. 12 seconds 
in duration) and 6 filters were used for the Laguerre expansion.  
 
Figure 1. Representative recording of ABP (arterial blood pressure) and CBFV (cerebral blood flow 
velocity) changes following inhalation of 5% CO2 in air. The first 300 seconds correspond to 
normocapnia (NC), and the last segment (120 s) to hypercapnia (HC).  
 
3.   Assessment of Cerebral Autoregulation  
3.1. Selection of Autoregulatory Parameters 
The final value of the models response (both linear and non linear) after applying an idealised 
step (see Figure 2A) is a commonly used approach [6, 8, 26] to assess  CA , and will be 
denoted as FVS (Final Value from the Step); in absent CA, FVS remains elevated [15]. Also, 
the amplitude at 3 seconds was calculated and expressed as a percentage change from the 
initial segment of the response (amplitude at 1 second) – denoted PCS (Percentage Change 
from the Step), as this was shown to be more robust than FVS [6]. 
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Figure 2. Step (a) and pressure-pulse (b) response for thirteen subjects (solid lines) estimated from a 5 
second-long FIR (finite impulse response) model. The inputs are shown as the bold dot-dashed- line.  
In  [27] a broadband filtered impulse (generated by applying a Gaussian window to a cosine 
wave at 0.08 Hz - Figure 2B and Figure 3A) was proposed as an alternative test input. This is 
visually similar to spontaneous fluctuations observed in recorded ABP signals (Figure 3B), 
and has a centre frequency in the range previously used in the assessment of CA from gain or 
phase [5, 8, 19].  The response to this input will be denominated as the pressure-pulse-
response (PPR).  
 
Figure 3. A. The pressure-pulse test input (sinusoid modulated by a Gaussian pulse - dotted line) and 
an example of the estimated response (%CBFV cerebral blood flow velocity - solid line). The 
parameters A1.5 and A7 (amplitudes at 1.5 and 7 seconds respectively) are also shown. B. Autospectra 
of ABP (arterial blood pressure) for one typical subject (solid line) and of the pressure-pulse input - 
(dotted line). The latter aims to emulate the peak of the former just below 0.1 Hz.  
 
Figure 2B and 3A show the expected left-shift (phase lead) in the PPR [7] resulting from the 
high-pass characteristics of the autoregulatory response [5, 14]. Results from preliminary 
work [13]  based on  simulations using   Tiecks model [15] and recorded data showed that the 
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PPR at 1.5 seconds (A1.5) and the amplitude at 7 seconds (A7) (as shown in Fig. 3A) provide 
good separation of different levels of CA and are thus selected for inclusion in the  current 
study. 
From transfer function analysis the average phase (Pha) and coherence (Coh) were estimated 
in the frequency range from 0.07 Hz to 0.2 Hz [5, 24]. Using the correlation method [18], Mx 
was estimated as the average Pearson’s correlation coefficient of four equal segments of the 
%ABP and %CBFV time series. The Autoregulatory Index ARI was calculated by evaluating 
the set of models proposed in [15] using the parameter values given by the authors. In each 
recording, the model was applied to the %ABP signal and the model leading to the highest 
correlation coefficient between the model generated velocity and the measured %CBFV 
determined the ARI. A parametric model based on the coefficients of a first-order (two 
coefficients) FIR filter [9] was also evaluated; the second coefficient of the filter provided an 
additional autoregulatory parameter (H1). 
For the nonlinear model, only the parameters extracted from the step response (FVS and PCS) 
and from PPR (A1.5 and A7) were used.  
3.2. Statistical Analysis 
In order to compare the goodness of fit of different models, the velocity predicted by each 
model from the recorded ABP data was compared to the measured data and the normalised 
mean square error (NMSE) was calculated. This is defined as the mean-square value of the 
difference between the predicted and measured velocity normalised by the mean-square of the 
measured velocity. Cross-validation was applied on the baseline data, with signals divided 
into two equal segments of 150s, one for training and the other for validation and NMSE 
calculate over the latter. Average values (after swapping the segments) were recorded. Cross-
validation was not applied to the data during hypercapnia, due to the short length of data 
available in that condition.  
Changes in the autoregulatory parameters induced by increased pCO2 were tested using paired 
t-tests. Inter-subject variability was assessed by calculating the standard deviation of the 
estimated parameters for all subjects during normo- and hypercapnia, and averaging the result; 
this will be denominated SD. In order to compare the performance of different parameters, 
whose values are all on quite different scales, SD was normalized by the difference in mean 
value between NC and HC. This will be referred to as the normalized standard deviation 
(SDn).  
Estimation errors in CA parameters, reflecting the repeatability or intra-subject variability of 
measurements, were assessed using Monte Carlo simulations. To this end, 100 simulated 
signals were generated for each of the recordings. Surrogate %CBFV signals were generated 
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by applying the identified models (linear or non-linear) to the %ABP signals and then adding 
random noise to simulate residuals. The noise was modelled based on the residual error in 
%CBFV (i.e. the signal component that cannot be explained by applying the identified models 
to the %ABP signals) using an AR model of order 8 selected according to Akaike’s 
information criterion [28]. Then for each of the 100 simulated signals, each of the CA 
parameters was estimated, and the standard deviation of these gives the intra-subject (within 
subject) variability. The mean value across the 13 subjects was calculated and also normalized 
by the parameter’s mean difference between normocapnia and hypercapnia (as for SDn) and 
denoted by mSDn. Low values of SDn and mSDn thus indicate low dispersion and/or wide 
separation between groups indicating improved ability to distinguish between normal and 
impaired CA.  
The Shapiro-Wilks test was used to assess normality of all the data sets before applying 
parametric statistical tests, and subsequently applied parametric and non-parametric statistical 
test accordingly.  To compare the fit of different models we used repeated two-way ANOVA 
in order to test for the combined effects of modelling techniques and of subjects. We used k-
repeated samples Friedman tests to evaluate the differences of intra-subject variability (as 
obtained from Monte Carlo simulations), as these were not normally distributed.  Inter-subject 
variability was evaluated by bootstrap followed by randomization. This approach was tested 
on simulated data under the null hypothesis, and showed the expected false positive rate.   
 
4. Results 
Mean CBFVs were significantly different between normo- and hypercapnia (p≈0.02); in all 13 
subjects mean CBFV increased after CO2 inhalation, indicating effective cerebrovascular 
reactivity and compliance with the protocol. 
4.1. Model Performance  
Table 1 shows the normalised mean-square error in fitting different models to the data.  
There was no significant difference between models (ANOVA p > 0.05); pairwise 
comparisons using the Bonferroni correction for revealed that the fifth order FIR model 
offered an overall improvement in NMSE compared to the first order FIR model (p < 0.05) 
but not over the W-L model. 
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Table 1. Mean ± standard deviation  NMSE (normalised mean square error) across 13 
subjects for the different models applied to the baseline recordings.  
4.2.  Assessment of Cerebral Autoregulation 
The different autoregulatory parameters are shown in Table 2 and performance indexes in 
Figure 4.  
 
Table 2. Autoregulatory parameters: mean and standard deviation from the thirteen subjects. 
 
For all parameters significant differences were found between NC (normocapnia) and HC 
(hypercapnia) using paired t-tests (Figure 4), suggesting that all are able to detect the expected 
impairment in CA.  
4.2.1. Inter-subject variability 
Autoregulatory parameters (see Figure 4) with small SDn indicate good separation between 
NC and HC. Amongst the parameters studied A1.5 (linear model – to be denoted as A1.5-L, 
with similar notation for other parameters), A7-NL (non-linear model), H1 and PCS-L, had 
the lowest SDn and FVS the highest. Although, the modelling approach used can reduce the 
inter-subject variability, no significant differences were observed for SDn between linear and 
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nonlinear models (ANOVA, p>0.05). The most notable results from the pairwise 
randomization tests between all parameters for  SDn were that FVS-L was significantly 
(p≤0.05) worse than A1.5-L, A7-L and PCS-L and (at p≤0.1) A1.5-L outperformed ARI, 
A1.5-NL and FVS,  and A7-L outperformed A1.5-NL and FVS-L.  
 
 
Figure 4.  Comparison of the different autoregulatory parameters. L (linear) and NL (non-linear) 
models respectively. Test of difference between NC (normocapnia and HC (hypercapnia): + p < 0.0005, 
* p < 0.005, o p<0.05. 
4.2.2. Intra-subject variability 
Conventional parameters extracted from the frequency response (Mx, Pha, Coh) as well as 
A1.5-L,  A7-L and A7-NL were relatively robust to noise (low mSDn); H1 performed 
particularly well (Figure 4). There were no significant differences in the variability of 
estimates between normocapnia and hypercapnia ( p>0.05 for all tests). 
Friedman test (k-related samples) showed significant differences in the set of thirteen 
parameters  (p =0.015). Post-hoc analysis was also carried out (Wilcoxon signed-ranked test 
and Bonferroni correction, p < 0.0015), to explore data further. Given the large number of 
parameters in the test, this was only applied to H1 (which was significant against A7-L, FVS-




5. Discussion  
5.1. Major Findings 
In this exploratory study, autoregulatory parameters with the lowest intra-subject variability 
(relative to the difference between NC and HC) are H1, A1.5-L and PCS-L as well as A7- 
(both L and NL). For inter-subject variability it is A1.5-L, A7-NL, PCS-L and H1 that 
performed best, in this sample. FVS-L and FVS-NL performed consistently poorly. 
A more detailed analysis of the major findings as well as the limitations of the current work 
follows.  
5.2. Inter-subject variability 
In previous work, the high inter-subject variability of a number of measures of cerebral blood 
flow control and poor repeatability has been noted [9, 25, 29]. In some of the earlier work [8, 
13, 25, 30] the primary concern has been with how well different models fit the data. This 
however is only an intermediate step in addressing the main challenge: quantifying CA when 
only spontaneous fluctuations in ABP and CBFV are present. The ultimate aim is to extract a 
single clinically (or physiologically) relevant measure of CA. The results in this work showed 
that the choice of model and parameters can notably change the variability in the estimates. 
The current work is probably the most extensive comparison between different parameters of 
CA calculated from spontaneous variations published to date.  
In the continuing absence of a gold-standard measure of CA, we take as criteria for assessing 
performance the ability to distinguish between normal (during normo-capnia) and impaired 
(during hypercapnia) CA, in healthy adults. The current work also moves beyond the more 
established ‘test inputs’ that give impulse, step or frequency (i.e. sine-wave) responses, by 
using a ‘test input’ that is physiologically more realistic, in the form of a broad-band pressure 
pulse. The results have shown lower dispersion in some of the measures extracted from the 
pulse response compared to traditional autoregulatory parameters (ARI, Phase, Mx, Coh, 
FVS), as indicated by SDn and mSDn. Although by the appropriate selection of the 
autoregulatory parameter the separation between normal and impaired condition can be 
increased, even for the best performing parameters (H1, A15-L, PCS-L and A7-NL) the SDn 
(i.e. the ratio of the between subjects standard deviation of parameter, to the mean difference 
between normocapnia and hypercapnia) is large, at approximately 0.6 and only in a few were 
some parameters found to outperform others.  
5.3. Intra-subject variability 
The estimated intra-subject variability (mSDn) was notably large compared to the dispersion 
between subjects (SDn), ranging from 25 to 90 %. In the Monte Carlo simulations for the 
calculation of mSDn added stationary noise was assumed, with time-invariant CA. This is the 
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usual assumption made in estimating confidence limits in system identification e.g. [31] but 
requires further investigation following on from some recent studies on the dynamics of CA 
[23, 32]. In the current work the estimated intra-subject variability can however be interpreted 
as the dispersion of estimates to be expected if the source of errors were only added noise 
rather than less tractable physiological variation.   
Previous studies have shown considerable intra-subject variation for repeated thigh cuff tests 
[33], repeated recordings with spontaneous fluctuations [22, 25] as well as recordings with 
controlled breathing where a sliding window was used to estimate short-term variability [25]. 
Previous analyses that concentrated on the performance of the ARI [25, 32, 33] have shown 
large variations over time and sudden drops to zero of this index. Although rigorous studies 
have not been performed to understand the source of this variability, this may be due to the 
constraint that the Aaslid’s model [15] imposes on the index as it only uses a set of ten filters 
[25]. Temporary absence of autoregulatory responses have also been observed in model-free 
analysis of spontaneous transients in blood pressure [26]. While such phenomena may reflect 
genuine temporary absences of CA they could also be the result of spontaneous variations in 
CBFV that are unrelated to ABP fluctuations ‘masking’ autoregulatory responses.  
H1 presented the most robust estimate in terms of intra-subject variability, as may be expected 
following the principle of parsimony, given that it has the smallest number of free parameters 
in the model. It should be noted that the model fit for this simplest of linear filters was poor in 
the training set (Table 1), and worse than the fifth order linear model in the validation data. 
On the other hand, the most sophisticated model tested (W-L) provided the best fit to the 
training data, but worst performance in the validation data (showing clear evidence of 
overfitting).  However both models provided good measures of CA. It is clear that model fit 
alone is not a good indicator for performance in assessing CA. 
5.4. Limitations   
There are clearly an almost infinite number of possible parameters that could be used to assess 
CA, and in the current work only a subset was considered. Given the relatively small sample 
of recordings available, some caution has to be exercised in interpreting the results, as the 
relative performance of the methods may reflect peculiarities in the data set available. 
However, the large differences in performance observed, and statistically significant 
differences noted probably do indicate which approaches are more promising for further 
study. Such studies should include repeated recordings of step-wise changes of EtCO2 and 
longer periods of baseline and in particular hypercapnia, as well as more subjects to allow 
more robust estimates of the intra- and inter-subject variability. Ideally, one would wish to 
compare equal-length recordings of normocapnia and hypercapnia, though the lengths used 
here are compatible with those used in other studies. Shorter data lengths are expected to 
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increase intra-subject variability, but in this work, a decrease in standard deviation  between 
NC and HC (table 2), was observed more often (8/13) than an increase (4/13); HC seems to be 
giving more stable estimates of CA than NC, for the same length of data.   
Within the parameters chosen for analysis here, there are also alternatives that should be 
considered: here we normalized both ABP and CBFV signals by their mean value, as used in 
some previous works; others have not done so (e.g. [34]), and results may thus be quite 
different for those CA parameters that are based on amplitude. For those parameters based on 
signal morphology only (Coh, Ph, ARI, Mx, PCS-L), normalization will not affect the 
results. For the frequency band for the transfer analysis based parameters (Pha, Coh), we 
have chosen the ‘low-frequency range’ (0.07 Hz to 0.2 Hz), where others have preferred lower 
frequency bands (e.g. [22]). As argued in [4], autoregulation is more active at lower 
frequencies, but also more prone to artefacts; CO2 in particular has a strong influence at the 
very low frequencies [12]. Better performance of a given parameter in one frequency band 
does not imply that it would also be better in a different band. Clearly, similar analysis to that 
carried out here is required on alternative CA parameters – using a larger dataset to ensure 
sufficient statistical power in the analysis.  
The strong scatter in results may be due not only to noise in the signals and differences among 
subjects but also the influence of other physiological variables such as pCO2, pO2, cerebral 
metabolic rate, and intracranial and venous pressure which were not analysed here. Even 
though studies including multivariate models have been published [30, 35], so far there has 
been little analysis as to whether this type of models may offer an improvement in terms of 
separation between normal and impaired conditions compared to the univariate approaches. 
This issue needs to be addressed in further studies.  
In the absence of a gold-standard for measuring CA, a comparison was made between 
normocapnia (with assumed active CA) and hypercapnia (inducing temporary impairment). 
Other studies e.g. [36] have used patient outcome as a measure in comparing methods to 
assess CA. The use of CO2 as a means to temporarily induce impaired CA is open to 
questioning. Clearly, the parameters considered all respond to hypercapnia, and in a manner 
that would be expected from the usual concept of autoregulation. However, given the 
complexity of the mechanisms controlling cerebral blood flow [21], one cannot be certain  
whether these parameters directly reflect autoregulation or some (related) physiological 
phenomenon. Furthermore it is possible that different clinical conditions (or CO2 levels) have 
distinct effects [1] and that a single measure of CA may not be optimal for all applications 
[37]. Throughout this paper we have assumed (as does most of the cited literature) that the 
parameters used measure cerebral autoregulation, However, given the complexity of the 
physiology and the often poor correlation found between parameters that have all been  
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considered to measure CA ([38]), they may not all reflect identical  phenomena of 
cerebrovascular control. In the current paper we have expanded on previous work, but 
remained firmly within the premise of most of these studies, by comparing the performance of 
different individual CA parameters based on the established protocol of normocapnia and 
hypercapnia, and exploiting spontaneous variability in signals. Further work to refine the 
concept of autoregulation, improve understanding of its physiology and link these to clinically 
feasible and robust measurement methods, is still required.  
6. Conclusions  
Among the parameters of CA examined, the amplitude of the pressure pulse response (PPR)  
A1.5 (linear model) and A7-(L and NL)showed the clearest distinctions between the different 
levels of CA. However, the results obtained from H1 suggest that this parameter, estimated 
from a very simple model shows the smallest normalized intra-subject variability (estimation 
error - mSDn) with good inter-subject variability (SDn), may be the method of choice. This 
method also lends itself well to the analysis of relatively short data segments and thus would 
be best suited for further studies of time-varying (adaptive) estimates of dynamics in cerebral 
blood flow control.  
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